• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Epidemiol . Clinical characteristics and risk factors for severe outcomes of novel coronavirus infection, January-March 2020, Japan

tetano

Editor, Senior Moderator
J Epidemiol


. 2021 May 29.
doi: 10.2188/jea.JE20200519. Online ahead of print.
Clinical characteristics and risk factors for severe outcomes of novel coronavirus infection, January-March 2020, Japan


Yuuki Tsuchihashi[SUP] 1 [/SUP], Yuzo Arima[SUP] 1 [/SUP], Takuri Takahashi[SUP] 1 [/SUP], Kazuhiko Kanou[SUP] 1 [/SUP], Yusuke Kobayashi[SUP] 1 [/SUP], Tomimasa Sunagawa[SUP] 1 [/SUP], Motoi Suzuki[SUP] 1 [/SUP]



Affiliations
Free article

Abstract

BackgroundNotifications of novel coronavirus infections increased in early 2020 in Japan. We described characteristics of novel coronavirus infection cases and analyzed risk factors for severe outcomes.MethodsCases were persons with laboratory-confirmed novel coronavirus infection reported under national surveillance between January and March 2020. Clinical characteristics were described, and factors associated with severe outcomes (intensive care unit [ICU] admission, invasive ventilation/death) were analyzed using Poisson regression.ResultsAmong the 516 cases analyzed, median age was 60 years (range: 1-97 years) and 285 (55%) were male. Common symptoms/signs were fever (375/475, 79%), cough (353/465, 76%), and pneumonia (245/387, 63%). Ten (2%) cases died. Of the 348 cases with data, 50 (14%) required invasive ventilation. Adjusted for each other, male gender and 1-year increase in age were associated with ICU admission (risk ratio (RR) 4.18; 95% confidence interval (CI), 1.69-10.32 and RR 1.05; 95%CI, 1.03-1.08, respectively) and invasive ventilation/death (RR 2.79; 95%CI, 1.49-5.21 and RR 1.06; 95%CI, 1.04-1.08). Diabetes, dyslipidemia, hyperuricemia, and lung diseases were also associated with severe outcomes. Of the 80 cases asymptomatic at hospitalization, 40 developed symptoms and five of them >70 years of age required invasive ventilation.ConclusionsThe early stage of the novel coronavirus epidemic in Japan disproportionately affected the elderly. Older age, male gender, and underlying conditions were associated with severe outcomes. Notably, some elderly case-patients who were asymptomatic at diagnosis and promptly hospitalized still went on to develop severe disease, indicating the importance of careful monitoring of certain populations.

Keywords: SARS-CoV-2; clinical characteristic; epidemiology; risk factor; surveillance.
 
Back
Top Bottom